The NanoBase™ Architecture

Most delivery systems in personal care still answer to a number invented in 1949. When William Griffin published the Hydrophile-Lipophile Balance, HLB, he handed formulators a single dial: match an emulsifier’s HLB value to an oil’s requirement and the emulsion resists separating. It was an elegant fix for its era. Three-quarters of a century on, most systems marketed as advanced are still HLB in newer packaging, tuned to stop one thing from breaking.

NanoBase™ starts from a different question. Not “what single balance keeps this from separating?” but “what if three distinct nano-domains were engineered to coexist, on purpose, inside one pourable system?” That shift is the entire idea. We call it NanoBase™ Logic.

What NanoBase™ actually is

NanoBase™ is a tri-domain nano-colloidal architecture: an aqueous system that is itself the continuous phase, pourable, water-thin, and stable, not an emulsion you must nurse against separation. Within it are three engineered populations, each a different morphology built to carry a different class of active:

• a nanoemulsion domain, for lipophilic actives and oils;
• a nanoliposomal domain, for amphiphilic actives and peptides;
• a micellar domain, for hydrophilic and surface-active actives.

These three are not blended into an average. They coexist as separate compartments, each doing the job it is shaped for. If HLB Logic is a single thermostat for one room, NanoBase™ Logic is a building with three purpose-built rooms, each conditioned for a different occupant.

Logic versus logic: NanoBase™ and HLB

This is not a faster version of HLB. It is a different design logic that supersedes it. Where HLB Logic balances one number so a system does not fall apart, NanoBase™ Logic makes several nano-domains coexist so each active class rides the morphology it belongs on.

The three domains and what each carries

The purpose of three domains is match. A peptide does not behave like a botanical oil, and neither behaves like a water-soluble humectant. Force all three into one carrier and you compromise on all three. Give each its own home, and a formulator is choosing which domain to load rather than fighting a single emulsion.

The electrostatic wall: DLVO as a design principle

A fair question follows at once: if three different nano-populations share one liquid, why do they not merge, ripen, or crash out? The answer is the principle at the core of the Architecture, an electrostatic barrier we reason about through DLVO theory (Derjaguin, Landau, Verwey, Overbeek), the classical account of colloidal stability. DLVO is cited for the established framework; these authors have not evaluated NanoBase™.

In DLVO terms, two approaching particles feel competing forces: an attraction pulling them together and an electrostatic repulsion pushing them apart. Engineer the interfacial charge so repulsion dominates across the distances that matter, and you raise an energy barrier, a wall, the domains cannot easily climb. That wall lets three morphologies share one continuous phase without collapsing into one, holding coexistence stable by design rather than by luck.

Two points of discipline belong here. First, the electrostatic wall is a design principle, the intent we build toward, not a certificate: we do not publish it as a measured assay or a reported charge value. Second, the physics is conventional. Nothing in NanoBase™ bends DLVO or thermodynamics; we apply those laws deliberately instead of settling for the single outcome the field usually asks of them.

Reading the Architecture: DLS and the multimodal signature

Every batch is characterized by dynamic light scattering, DLS, the workhorse method for sizing sub-micron colloids: it watches how particles scatter light as they diffuse and reconstructs a size distribution.

This is where a genuinely tri-domain system parts ways with a conventional one. Legacy carriers are engineered toward a single narrow mode: one population, one peak, as tight as possible. A tri-domain architecture is not trying to be one peak. Because three engineered populations coexist, its distribution resolves as a multimodal signature, more than one mode, each consistent with a designed domain rather than a single spike forced onto one size.

Read through an old lens, that breadth looks like polydispersity to be scrubbed away. Read through NanoBase™ Logic, it is the design doing its job. DLS resolves a reproducible multimodal size distribution consistent with the tri-domain design. DLS reports hydrodynamic size, not structure; direct morphological confirmation (cryo-TEM, SAXS) is planned future work, not data we hold today.

Why coexistence is the defensible hook

For most of colloid science, one system meant one morphology. An emulsion was an emulsion; a liposome dispersion was a liposome dispersion; mixed or drifting morphologies read as instability, a defect to engineer out. That convention is what NanoBase™ inverts: the coexistence the field spent decades suppressing is the thing we engineer on purpose.

That uniqueness is a claim about design convention, not physics. We are not overturning a law; DLVO and thermodynamics are the very tools we lean on. What is new is the intent: to our knowledge, the only commercially available tri-domain nano-colloidal architecture of its kind, engineered so three domains coexist and resolve by DLS as a reproducible multimodal size distribution, where the tradition was to force everything into one. The rationale and characterization are set out in two preprints on Zenodo, the first here and the second here. Both are preprints describing the Architecture, offered for technical scrutiny, not peer-reviewed endpoints.

An empty chassis you build on

NanoBase™ ships as a finished cosmetic raw material with its own INCI, manufactured by Pensive Beauty® from a boutique nanoscience lab and a 10,000 sq ft production facility. On its own it is deliberately empty: an unloaded chassis, a leave-on aqueous architecture for intact skin, carrying no actives until a brand adds them.

That top layer is where real production happens. A brand, or its contract manufacturer, takes the Architecture and loads its own actives by gentle, room-temperature mixing, letting each active partition toward the domain its chemistry prefers. The finished formula built on top of NanoBase™ is cold-processable and producible at any qualified contract manufacturer on standard equipment: no high-shear homogenizer, no heat-and-hold, no specialized nano-line. The nanoscience is already engineered into the chassis; the brand’s work is formulation, not colloid engineering from scratch.

Honest scope: what we run, what we cite

Two commitments keep this page honest. First, characterization. DLS is the assay we run on the Architecture, and we report only what it shows: a multimodal size signature consistent with the designed domains. We do not present tape-strip, Franz-cell, or confocal-Raman data, because we do not generate it. Our vocabulary is deposition and bioavailability; we make no claims about what happens below the skin surface.

Second, rationale. The case for why sub-200nm delivery is worth engineering does not come from us. It comes from a substantial body of independent, peer-reviewed literature on sub-200nm carriers, which reports improved deposition and bioavailability of actives from nano-scaled systems relative to their coarse counterparts. Where we point to that benefit, it is the published finding of other laboratories, attributed to them; never a NanoBase™ result and never a head-to-head test against an HLB system. NanoBase™ itself carries no actives, so it is not clinically tested and makes no disease or structure-function claims. We characterize the Architecture; what actives do once loaded is the brand’s to substantiate.

Where NanoBase™ stands

The Architecture is already in use with tier-1 global manufacturers and independent brands. NANOBASE is the subject of a US trademark application in Class 001, with first commercial use in 2025, and it has been adopted into Eastern Virginia Career College’s Medical Aesthetics Certificate Program, effective 2027, as part of how its next cohort learns modern delivery. That adoption is a curricular fact; any individual endorsement is offered in a personal capacity.

The logic and the blueprint are free. The manufactured architecture and the partnership are the product. If you formulate, the quickest way to understand NanoBase™ is to design on it. Try the free NanoBase™ AI Chemist to scope a finished formula across the three domains, or request a sample and full spec to evaluate the Architecture on your own bench. For the logic-versus-logic breakdown, read NanoBase™ vs HLB; explore the NanoBase™ family; for methods and preprints, visit research and evidence; for defined terms, see the glossary; and to see how brands build with it, meet our partners and the skincare formulation lab.